Demerol Injection, Solution
Product Images NDC 0409-1181

30 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Demerol (NDC 0409-1181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Demerol 01)

Chemical Structure (Demerol 01)
Chemical structure of DEMEROL (meperidine) hydrochloride, showing the molecular arrangement including the piperidine ring, ester group, and phenyl ring, alongside the hydrogen chloride salt form.*
FDA Label Image

Logo (Demerol 02)

FDA Label Image

Demerol 02a

Demerol 02a
Instructional diagram for use of the NexJect 1mL Prefilled Syringe showing visual inspection steps before administration, including checking for broken tamper-evident seals, cracked glass, leaking drug, expired date, and particulate matter. Includes warnings not to use if seals are broken and notes about matching medication order details and sterile handling.*
FDA Label Image

Demerol 02b

Demerol 02b
Illustration showing instructions for opening a DEMEROL prefilled syringe. Step 1 demonstrates twisting off the plunger rod cover to break the tamper-evident seal and discarding the cover. Step 2 shows twisting the luer tip cover to break its tamper-evident seal and then pulling the luer tip cover off the syringe to discard it.*
FDA Label Image

Demerol 02c

Demerol 02c
Instructional diagram illustrating steps 3 to 5 for preparing and administering DEMEROL injection. It visually guides expelling air by advancing the plunger, adjusting the dose by expelling extra volume from the syringe as needed, and connecting the luer to an access device or needle for medication delivery.*
FDA Label Image

Demerol 02d

FDA Label Image

Principal Display Panel (25 mg/mL Cartridge Label)

Principal Display Panel (25 mg/mL Cartridge Label)
Label for Demerol 25 mg/mL, a meperidine HCl injection, USP in a 1 mL single-dose cartridge with Luer Lock. Distributed by Hospira, Inc., Lake Forest, IL. Includes NDC 0409-1176-03, Rx only, lot and expiration date fields, and Hospira logo.*
FDA Label Image

Principal Display Panel (25 mg/mL Cartridge Carton)

Principal Display Panel (25 mg/mL Cartridge Carton)
Box packaging label for Demerol 25 mg/mL injection, USP by Hospira, Inc. It contains 1 mL single-dose sterile cartridge units with Luer Lock, sold in a 10 Carpuject pack. The label includes dosage form information, usage routes (intramuscular, subcutaneous, intravenous), handling instructions, and storage conditions. The product is meperidine hydrochloride injection.*
FDA Label Image

Principal Display Panel (50 mg/mL Cartridge Label)

Principal Display Panel (50 mg/mL Cartridge Label)
Demerol 50 mg/mL single-dose cartridge unit label for meperidine HCl injection, USP. The sterile cartridge includes a Luer Lock and holds 1 mL volume. The label shows the NDC 0409-1178-03, Rx only status, and is distributed by Hospira, Inc., Lake Forest, IL. Lot and expiration date fields are visible but not filled.*
FDA Label Image

Principal Display Panel (50 mg/mL Cartridge Carton)

Principal Display Panel (50 mg/mL Cartridge Carton)
Demerol 50 mg/mL sterile cartridge unit label by Hospira, Inc. The label is for 1 mL single-dose Carpuject sterile cartridge units with Luer lock, containing meperidine hydrochloride injection, USP. It states it is for intramuscular, subcutaneous, or intravenous use and includes 10 cartridges per package. The packaging emphasizes use only with Carpuject holders and includes storage and formulation details.*
FDA Label Image

Principal Display Panel (75 mg/mL Cartridge Label)

Principal Display Panel (75 mg/mL Cartridge Label)
Label for Demerol 75 mg/mL sterile cartridge unit with Luer Lock, containing meperidine HCl injection, USP. It is a 1 mL single-dose cartridge labeled for prescription use only. Distributed by Hospira, Inc., Lake Forest, IL. The label includes volume measurement increments from 0.5 mL to 2 mL and space for lot and expiration date details.*
FDA Label Image

Principal Display Panel (75 mg/mL Cartridge Carton)

Principal Display Panel (75 mg/mL Cartridge Carton)
Packaging label for Demerol (meperidine hydrochloride) injection, USP, 75 mg/mL single-dose sterile cartridge units. The carton contains 10 Carpuject sterile cartridges with Luer Lock, distributed by Hospira, Inc. The label notes use for intramuscular, subcutaneous, or intravenous injection, and states cartridges are to be used only with Carpuject holders.*
FDA Label Image

Principal Display Panel (100 mg/mL Cartridge Label)

Principal Display Panel (100 mg/mL Cartridge Label)
Label for Demerol 100 mg/mL sterile cartridge unit with Luer Lock, single-dose, for injection. Includes active ingredient meperidine HCl. Label indicates Rx only, distributor Hospira, Inc., Lake Forest, IL, along with volume graduations from 0.5 mL to 2 mL and placeholder fields for lot and expiration date.*
FDA Label Image

Principal Display Panel (100 mg/mL Cartridge Carton)

Principal Display Panel (100 mg/mL Cartridge Carton)
Packaging label for Demerol (meperidine hydrochloride injection) USP 100 mg/mL sterile cartridge units. The label indicates a 1 mL single-dose cartridge, with 10 Carpuject units per package, designed with Luer lock. Distributed by Hospira, Inc., the label includes usage instructions and storage conditions with tamper detection features visible.*
FDA Label Image

Principal Display Panel (25 mg/0.5 mL Ampule Label)

Principal Display Panel (25 mg/0.5 mL Ampule Label)
Demerol 50 mg/mL (1500 mg/30 mL) sterile aqueous injection vial. Multiple-dose vial with 30 mL volume for intramuscular, subcutaneous, or intravenous use. Distributed by Hospira, Inc., Lake Forest, IL USA. Label includes storage and preservative information.*
FDA Label Image

Principal Display Panel (25 mg/0.5 mL Ampule Dose Pak)

Principal Display Panel (25 mg/0.5 mL Ampule Dose Pak)
Packaging label for Demerol 1500 mg/30 mL (50 mg/mL) meperidine hydrochloride injection, USP, a sterile aqueous injection. The label states it is for intramuscular, subcutaneous, or intravenous use. The 30 mL multiple-dose vial is distributed by Hospira, Inc. The label includes the controlled substance schedule II symbol and storage instructions.*
FDA Label Image

Principal Display Panel (25 mg/0.5 mL Ampule Dose Pak Carton)

Principal Display Panel (25 mg/0.5 mL Ampule Dose Pak Carton)
Demerol 100 mg/mL sterile aqueous injection in a 20 mL multiple-dose vial. The label shows meperidine hydrochloride injection, USP with a total of 2000 mg per vial, distributed by Hospira, Inc. It includes dosing instructions for intramuscular, subcutaneous, or intravenous use, and storage conditions at 20 to 25°C (68 to 77°F).*
FDA Label Image

Principal Display Panel (50 mg/mL Ampule Label)

Principal Display Panel (50 mg/mL Ampule Label)
Packaging label for Demerol 100 mg/mL (2000 mg/20 mL) meperidine hydrochloride injection, USP multiple-dose vial by Hospira, Inc. The sterile aqueous injection is indicated for intramuscular, subcutaneous, or intravenous use. The label includes dosage strength, NDC 0409-1201-20, preservative and pH adjustment details, storage instructions, and barcode.*
FDA Label Image

Principal Display Panel (50 mg/mL Ampule Dose Pak)

Principal Display Panel (50 mg/mL Ampule Dose Pak)
Label for Demerol 25 mg/mL (meperidine HCl injection, USP) by Hospira, Inc. The label includes volume markings for 0.5 mL and 1 mL doses and a product code PAA148095. The primary color scheme features brown and white areas with the product name and strength prominently displayed.*
FDA Label Image

Principal Display Panel (50 mg/mL Ampule Dose Pak Carton)

Principal Display Panel (50 mg/mL Ampule Dose Pak Carton)
Label for DEMEROL 25 mg/mL, meperidine HCl injection, USP in a 1 mL single-dose syringe by Hospira, Inc. The label indicates intramuscular, subcutaneous, or intravenous use. It includes a tamper seal area, NDC 0409-1362-11, lot and expiration date placeholders, and a barcode.*
FDA Label Image

Principal Display Panel (75 mg/1.5 mL Ampule Label)

Principal Display Panel (75 mg/1.5 mL Ampule Label)
Demerol 25 mg/mL meperidine hydrochloride injection, USP packaging label for Hospira, Inc. This injectable product is intended for intramuscular, subcutaneous, or intravenous use. The package includes 10 NexJect single-dose 1 mL syringes with luer lock. Storage instructions specify controlled room temperature (20 to 25°C). The label displays the NDC 0409-1362-01 and emphasizes that the product is prescription only.*
FDA Label Image

Principal Display Panel (75 mg/1.5 mL Ampule Dose Pak)

Principal Display Panel (75 mg/1.5 mL Ampule Dose Pak)
Demerol 50 mg/mL label shows the product name with the active ingredient meperidine HCl injection, USP. The label includes black volume markings indicating 0.5 mL and 1 mL increments. The labeler is Hospira, Inc., as indicated by the trademark symbol and design elements.*
FDA Label Image

Principal Display Panel (75 mg/1.5 mL Ampule Dose Pak Carton)

Principal Display Panel (75 mg/1.5 mL Ampule Dose Pak Carton)
Label for DEMEROL 50 mg/mL meperidine HCl injection, USP in a 1 mL single-dose syringe. The label includes dosing form indications for intramuscular, subcutaneous, or intravenous use, and features tamper seal instructions marked 'TWIST & PULL.' Labeler is Hospira, Inc., and the NDC is 0409-1418-11.*
FDA Label Image

Principal Display Panel (100 mg/2 mL Ampule Label)

Principal Display Panel (100 mg/2 mL Ampule Label)
Demerol 50 mg/mL meperidine hydrochloride injection label for 10 NexJect 1 mL single-dose syringes with luer lock. Intended for intramuscular, subcutaneous, or intravenous use. Label indicates storage at controlled room temperature and notes sterile aqueous injection. Manufactured by Hospira, Inc.*
FDA Label Image

Principal Display Panel (100 mg/2 mL Ampule Dose Pak)

Principal Display Panel (100 mg/2 mL Ampule Dose Pak)
Label for DEMEROL (meperidine HCl injection, USP) showing a strength of 75 mg/mL. The label includes volume measurement markings for 0.5 mL and 1 mL increments. The labeler is not visible on this image.*
FDA Label Image

Principal Display Panel (100 mg/2 mL Ampule Dose Pak Carton)

Principal Display Panel (100 mg/2 mL Ampule Dose Pak Carton)
Label of Demerol meperidine HCl injection, USP showing 75 mg/mL strength. The label specifies the product is for intramuscular, subcutaneous, or intravenous use and comes in a 1 mL single-dose syringe. It also includes a tamper seal with instructions to twist and pull. The label is marked Rx only and is produced by Hospira, Inc.*
FDA Label Image

Principal Display Panel (100 mg/mL Ampule Label)

Principal Display Panel (100 mg/mL Ampule Label)
Demerol 75 mg/mL label for meperidine hydrochloride injection, USP by Hospira, Inc. The label specifies use for intramuscular, subcutaneous, or intravenous injection, provided as 10 single-dose 1 mL NexJect syringes with luer lock. It includes storage instructions, pH adjustment information, and mentions the product is sterile aqueous injection. The label also shows barcodes and serialization data.*
FDA Label Image

Principal Display Panel (100 mg/mL Ampule Dose Pak)

Principal Display Panel (100 mg/mL Ampule Dose Pak)
Demerol 100 mg/mL label for meperidine HCl injection, USP. The label includes volume markers for 0.5 mL and 1 mL and shows the Hospira, Inc. product with a lot or batch number PAA148385.*
FDA Label Image

Principal Display Panel (100 mg/mL Ampule Dose Pak Carton)

Principal Display Panel (100 mg/mL Ampule Dose Pak Carton)
Label for Demerol meperidine HCl injection, USP with a strength of 100 mg/mL in a 1 mL single-dose syringe. The label indicates intramuscular, subcutaneous, or intravenous use and is marked Rx only. It features a tamper seal and a barcode.*
FDA Label Image

Principal Display Panel (30 mL Vial Label)

Principal Display Panel (30 mL Vial Label)
Label of Demerol (meperidine hydrochloride) injection, USP, strength 100 mg/mL by Hospira, Inc. The label indicates use for intramuscular, subcutaneous, or intravenous administration. It includes packaging details for 10 NexJect 1 mL single-dose syringes with luer lock. Storage instructions and manufacturer location in Lake Forest, IL are present, along with barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.